Interested in the latest advancements in Abbott's portfolio? Connect with a rep to learn more: https://bit.ly/3jpCgFe.
Abbott | Neuromodulation
Medical Equipment Manufacturing
Austin, TX 19,522 followers
Stay connected with Abbott’s Neuromodulation business for news, resources and updates.
About us
Abbott’s Neuromodulation business offers innovative, convenient and effective therapy options for patients who suffer from chronic pain or movement disorders such as Parkinson’s disease and Essential Tremor. From neuromodulation to digital care, our technology helps patients live fuller lives by giving them greater control over their symptoms and simplifying physician follow-ups.
- Website
-
https://www.neuromodulation.abbott/us/en/homepage.html
External link for Abbott | Neuromodulation
- Industry
- Medical Equipment Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Austin, TX
Updates
-
Are you attending SXSW this week? Don’t miss our panel, “Revolutionizing Mental Healthcare with Implantable Devices” tomorrow. Join us as we share insights on the potential of innovative approaches to treating depression, like implantable devices. Learn more by visiting: https://abbo.tt/4h5iH0K. #SXSW2025 Deep Brain Stimulation (DBS) has not been approved by FDA for treatment-resistant depression (TRD) and the safety and effectiveness of DBS for TRD has not been established. For information on approved uses of DBS, please see Important Safety Information here: https://abbo.tt/405CGF7.
-
-
Join Us at SXSW 2025! We're excited to present our panel, “Revolutionizing Mental Healthcare with Implantable Devices”. Discover the potential of innovative approaches to treating depression and explore how we can make an impact for those in need of new options. Don't miss this insightful discussion. Learn more: https://abbo.tt/4h5iH0K. #SXSW2025 Deep Brain Stimulation (DBS) has not been approved by FDA for treatment-resistant depression (TRD) and the safety and effectiveness of DBS for TRD has not been established. For information on approved uses of DBS, please see Important Safety Information here: https://abbo.tt/405CGF7.
-
Explore the future of mental healthcare at #SXSW2025. Mark your calendars for our session: “Revolutionizing Mental Healthcare with Implantable Devices”. We'll delve into the potential of innovative treatments for depression and discuss ways to make an impact for those in need. Visit https://abbo.tt/4h5iH0K to learn more. Deep Brain Stimulation (DBS) has not been approved by FDA for treatment-resistant depression (TRD) and the safety and effectiveness of DBS for TRD has not been established. For information on approved uses of DBS, please see Important Safety Information here: https://abbo.tt/405CGF7.
-
-
Calling all Advanced Practice Providers! Don’t miss our webinar happening on February 26 at 6 p.m. CT where you’ll learn about our therapy options for your chronic pain patients & optimal patient selection. Register today: https://abbo.tt/40ObtHn.
-
-
Extend patient access with our NeuroSphere™ Digital Health app. Now you can support your patients with remote care solutions that help optimize the patient experience with neurostimulation therapy. Learn more: https://abbo.tt/40N47VY. #NeuroSphere Important Safety Info: https://bit.ly/44JcQJ1.
-
NeuroSphere™ Digital Health allows you to engage patients to track their progress from trial through implant to be informed of their conversations with providers and advocate for their needs. Learn how you can support your patients by visiting: https://abbo.tt/40N47VY. Important Safety Info: https://bit.ly/44JcQJ1.
-
With NeuroSphere™ Digital Health, you can educate patients who may benefit from neurostimulation, including access to on-demand education and, for permanently implanted patients, live product support from our Therapy Navigation Center. Learn more by visiting https://abbo.tt/40N47VY. #NeuroSphere Important Safety Info: https://bit.ly/44JcQJ1.
-
Elevate Care with our new NeuroSphere™ Digital Health app. Our intuitive suite of digital care offerings allows your patients to maximize their neurostimulation journey with on-demand educational resources, real-time patient reported outcomes during trial, and extended care beyond clinic walls through remote programming. Learn more: https://abbo.tt/40N47VY. #NeuroSphere Important Safety Info: https://bit.ly/44JcQJ1.
-
At #NANS25, join us at our booth for two exclusive demos of our latest innovations. See firsthand how our Next-Generation Delivery System* works and how our innovative digital solutions transform health care. Don’t miss this opportunity to see it in action! #AbbottAtNANS 📅 Date: Friday, January 31 🕒 Time: 9:40-10:00 a.m. 📍 Location: Exhibit Hall Abbott Booth 📅 Date: Saturday, February 1 🕒 Time: 9:40-10:00 a.m. 📍 Location: Exhibit Hall Abbott Booth Important Safety Information: https://bit.ly/44JcQJ1